Amgen Inc.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to tr…
Drug Manufacturers - General
US, Thousand Oaks [HQ]
AMGN/Financial Reporting
Income Statements
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14,642.00 | 15,053.00 | 15,582.00 | 17,265.00 | 18,676.00 | 20,063.00 | 21,662.00 | 22,991.00 | 22,849.00 | 23,747.00 | 23,362.00 | 25,424.00 | 25,979.00 | 26,323.00 | 28,190.00 | |
|
EPS
|
4.53 | 4.82 | 4.07 | 5.61 | 6.75 | 6.80 | 9.15 | 10.32 | 2.71 | 12.70 | 12.96 | 12.40 | 10.34 | 12.18 | 12.56 | |
| Diluted in mil. | 4.51 | 4.79 | 4.04 | 5.52 | 6.64 | 6.70 | 9.06 | 10.24 | 2.69 | 12.62 | 12.88 | 12.31 | 10.28 | 12.11 | 12.49 | |
|
Profit
|
12,551.00 | 12,833.00 | 13,155.00 | 14,347.00 | 15,330.00 | 15,641.00 | 17,435.00 | 18,829.00 | 18,780.00 | 19,646.00 | 19,006.00 | 19,265.00 | 19,525.00 | 19,917.00 | 19,739.00 | |
| Gross Margin | 85.72 | 85.25 | 84.42 | 83.10 | 82.08 | 77.96 | 80.49 | 81.90 | 82.19 | 82.73 | 81.35 | 75.77 | 75.16 | 75.66 | 70.02 | |
| Pre Tax | 5,204.00 | 5,317.00 | 4,150.00 | 5,009.00 | 5,265.00 | 5,585.00 | 7,978.00 | 9,163.00 | 9,597.00 | 9,545.00 | 9,138.00 | 8,133.00 | 6,701.00 | 7,346.00 | 7,855.00 | |
| Profit Margin | 35.54 | 35.32 | 26.63 | 29.01 | 28.19 | 27.84 | 36.83 | 39.85 | 42.00 | 40.19 | 39.11 | 31.99 | 25.79 | 27.91 | 27.86 | |
| ETR | 11.51 | 12.98 | 11.25 | 13.26 | 3.49 | 7.65 | 13.02 | 15.73 | 79.38 | 12.06 | 14.18 | 10.68 | 12.06 | 10.81 | 14.49 | |
| Net | 4,605.00 | 4,627.00 | 3,683.00 | 4,345.00 | 5,081.00 | 5,158.00 | 6,939.00 | 7,722.00 | 1,979.00 | 8,394.00 | 7,842.00 | 7,264.00 | 5,893.00 | 6,552.00 | 6,717.00 | |
| Profit Margin | 31.45 | 30.74 | 23.64 | 25.17 | 27.21 | 25.71 | 32.03 | 33.59 | 8.66 | 35.35 | 33.57 | 28.57 | 22.68 | 24.89 | 23.83 | |
| EBITDA | 6,076.00 | 6,215.00 | 5,054.00 | 6,356.00 | 6,287.00 | 6,656.00 | 9,073.00 | 10,423.00 | 10,901.00 | 10,937.00 | 10,427.00 | 9,395.00 | 9,403.00 | 8,752.00 | 14,801.00 | |
| EBITDA Margin | 41.50 | 41.29 | 32.43 | 36.81 | 33.66 | 33.18 | 41.88 | 45.34 | 47.71 | 46.06 | 44.63 | 36.95 | 36.19 | 33.25 | 52.50 | |
| Operating Income | 5,506.00 | 5,545.00 | 4,312.00 | 5,577.00 | 5,867.00 | 6,191.00 | 8,470.00 | 9,794.00 | 9,973.00 | 10,263.00 | 9,674.00 | 5,794.00 | 6,005.00 | 5,335.00 | 7,897.00 | |
| Operating Margin | 37.60 | 36.84 | 27.67 | 32.30 | 31.41 | 30.86 | 39.10 | 42.60 | 43.65 | 43.22 | 41.41 | 22.79 | 23.11 | 20.27 | 28.01 | |
| Interest Income | 276.00 | 376.00 | 448.00 | 485.00 | 420.00 | 465.00 | 603.00 | 629.00 | 928.00 | 674.00 | 753.00 | 256.00 | 1,197.00 | 1,406.00 | 2,875.00 | |
| Loss | -9,136.00 | -9,508.00 | -11,270.00 | -11,688.00 | -12,809.00 | -13,872.00 | -13,192.00 | -13,197.00 | -12,876.00 | -13,484.00 | -13,688.00 | -16,285.00 | -16,835.00 | -16,757.00 | -20,293.00 | |
| Cost of Revenue | -2,091.00 | -2,220.00 | -2,427.00 | -2,918.00 | -3,346.00 | -4,422.00 | -4,227.00 | -4,162.00 | -4,069.00 | -4,101.00 | -4,356.00 | -6,159.00 | -6,454.00 | -6,406.00 | -8,451.00 | |
|
Operating Expenses
|
-7,045.00 | -7,288.00 | -8,843.00 | -8,770.00 | -9,463.00 | -9,450.00 | -8,965.00 | -9,035.00 | -8,807.00 | -9,383.00 | -9,332.00 | -10,126.00 | -10,381.00 | -10,351.00 | -11,842.00 | |
| R&D | -2,864.00 | -2,894.00 | -3,167.00 | -3,380.00 | -4,083.00 | -4,297.00 | -4,070.00 | -3,840.00 | -3,562.00 | -3,737.00 | -4,116.00 | -4,207.00 | -4,819.00 | -4,434.00 | -4,784.00 | |
| G&A | -3,820.00 | -3,983.00 | -4,486.00 | -4,801.00 | -5,184.00 | -4,699.00 | -4,846.00 | -5,062.00 | -4,870.00 | -5,332.00 | -4,361.00 | -4,768.00 | -4,525.00 | -4,573.00 | -5,532.00 | |
| SG&A | -3,820.00 | -3,983.00 | -4,486.00 | -4,801.00 | -5,184.00 | -4,699.00 | -4,846.00 | -5,062.00 | -4,870.00 | -5,332.00 | -5,150.00 | -5,730.00 | -5,368.00 | -5,414.00 | -6,179.00 | |
| S&M | - - | - - | - - | - - | - - | - - | -346.00 | -489.00 | -620.00 | -674.00 | -789.00 | -962.00 | -843.00 | -841.00 | -647.00 | |
| Depreciation and Amortization | -1,049.00 | -1,017.00 | -1,060.00 | -1,088.00 | -1,286.00 | -2,092.00 | -2,108.00 | -2,105.00 | -1,955.00 | -1,946.00 | -2,206.00 | -3,601.00 | -3,398.00 | -3,417.00 | -4,071.00 | |
| Interest Expenses | -578.00 | -604.00 | -610.00 | -1,053.00 | -1,022.00 | -1,071.00 | -1,095.00 | -1,260.00 | -1,304.00 | -1,392.00 | -1,289.00 | -1,262.00 | -1,197.00 | -1,406.00 | -2,875.00 | |
| Other Expenses | -302.00 | -228.00 | -896.00 | -568.00 | -602.00 | -606.00 | -492.00 | -631.00 | -376.00 | -718.00 | -536.00 | -2,339.00 | -696.00 | -2,011.00 | -2,833.00 | |
|
WA Shares Outstanding
|
1,016.00 | 960.00 | 905.00 | 775.00 | 753.00 | 759.00 | 758.00 | 748.00 | 731.00 | 661.00 | 605.00 | 586.00 | 570.00 | 538.00 | 535.00 | |
| Diluted | 1,021.00 | 965.00 | 912.00 | 787.00 | 765.00 | 770.00 | 766.00 | 754.00 | 735.00 | 665.00 | 609.00 | 590.00 | 573.00 | 541.00 | 538.00 |